Jeff Aronin nurtured role as chief executive officer and chairman of the biopharmaceutical investment and healthcare solutions development firm Paragon Bioscience. The company is known globally for its role in supporting the development of cutting-edge medicines, treatments and therapies. Paragon Bioscience provides the financing, resources and support services for companies like Precision BP, Decade, Harmony Biosciences and Castle Creek to do their groundbreaking research and development work and create medicines and methods for treating so of the most debilitating medical condition facing modern society.
What makes Paragon Bioscience unique is their ability to use biomedical innovation to improve the quality and length of the lives of countless people around the world suffering with over 6,000 different medical conditions. Paragon Biosciences puts the needs of the patient first and works with their portfolio of companies to understand the diseases they face and the science behind creating drugs and treatments for preventing and curing those conditions (https://about.me/jeffaronin). Paragon Biosciences invests in and serves as an incubator for top biotechnology companies with the staff, training and facilities to successfully address those unmet medical needs.
Since taking the top leadership position in Paragon Biosciences in 2010, Jeff Aronin has utilized his leadership experience and vast expertise in finance, brand marketing, strategic and business development, management and operations, as well as structuring and execution of corporate transactions to make the company an industry leader. Jeff Aronin has spent more than two decades managing the day-to-day operations of a number of major global corporations working in very tightly regulated industries. That made him an excellent choice to take the helm at Paragon Biosciences and help them to reach their full potential.
Before joining Paragon Bioscience Jeff Aronin held top executive positions with biopharmaceutical companies like Harmony Biosciences, Castle Creek Pharmaceuticals and Lundbeck, Inc. He also founded the biopharmaceutical company Ovation Pharmaceuticals Inc. in 2000 and served as its president and CEO until 2009. Aronin has a history of helping companies to solve the medical problems many deemed unsolvable through the disciplined use of targeted strategies to deal with specific clinical areas. Jeff Aronin continues that at Paragon Biosciences.